Femtosecond Laser Assisted Keratotomies for the Management of Corneal Astigmatism
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04676451 |
|
Recruitment Status :
Enrolling by invitation
First Posted : December 21, 2020
Last Update Posted : January 11, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Astigmatism Cataract | Device: Femto-AK | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 200 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | This is a prospective, single-center, single-arm, interventional clinical trial. Subjects that meet inclusion and exclusion criteria are invited to participate. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Femtosecond Laser Assisted Keratotomies for the Management of Corneal Astigmatism |
| Actual Study Start Date : | May 14, 2018 |
| Estimated Primary Completion Date : | December 2024 |
| Estimated Study Completion Date : | December 2024 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Femto-AK Patients
Femtosecond laser assisted cataract surgery with creation of astigmatic keratotomies for the correction of corneal astigmatism.
|
Device: Femto-AK
Astigmatic Keratotomy / Arcuate Incisions for the correction of astigmatism |
- Keratometric Correction Index [ Time Frame: 1 month ]
- Refractive Correction Index [ Time Frame: 1 month ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age: ≥18 years of age
- Sex: male or female
- Patients who are planned to undergo femtosecond laser-assisted cataract surgery with astigmatic keratotomy at the Schein Ernst Mishra Eye clinic within the next 60 days of their cataract consultation visit. Subjects with planned single or bilateral cataract eye surgeries are eligible. Planned opposite eye surgery must be within 2-4 weeks of first cataract surgery.
- Fluent in written and spoken English
Exclusion Criteria:
- Patients with corneal dystrophies, including anterior basement membrane dystrophy, keratoconus, and Fuch's endothelial corneal dystrophy.
- Age < 18 years
- Pregnant women
- Cognitive impairment
- Prisoners
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04676451
| United States, Pennsylvania | |
| Penn State Hershey Eye Center | |
| Hershey, Pennsylvania, United States, 17033 | |
| Responsible Party: | Seth M Pantanelli, Associate Professor of Ophthalmology, Milton S. Hershey Medical Center |
| ClinicalTrials.gov Identifier: | NCT04676451 |
| Other Study ID Numbers: |
8058 |
| First Posted: | December 21, 2020 Key Record Dates |
| Last Update Posted: | January 11, 2022 |
| Last Verified: | January 2022 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | Yes |
|
Astigmatism Cataract Femtosecond laser |
|
Cataract Astigmatism Lens Diseases Eye Diseases Refractive Errors |

